• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Montreal Neurological Institute, McGill Univ, Montreal, QC, Canada

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Ofatumumab Reduces Clinical and Radiological Activity in People with Recently Diagnosed Treatment-naive Relapsing Multiple Sclerosis Irrespective of Baseline Serum Neurofilament Light Chain Levels

Author:Pardo, Gabriel   Kappos, Ludwig   Cross, Anne   Kuhle, Jens   Montalban, Xavier   Khachanova, Natalia   Bhatt, Alit   Piccolo, Rebecca   Xi, Jing   Boer, Ibolya   Arnold, Douglas   Alvarez, Enrique   Ziemssen, Tjalf   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.008  

Author Institution:Oklahoma Medical Research Foundation, Oklahoma City, OK  RC2NB, University Hospital Basel, Basel, Switzerland  Washington University School of Medicine, Clayton, MO  Neurologic Clinic and Policlinic and MS Center, Basel, Switzerland  Vall Hebron University Hospital-Multiple Sclerosis Centre of Catalonia, Barcelona, Spain  Russian National Research Medical University N.I. Pirgov, Moscow, Russian Federation  Novartis Healthcare Pvt. Ltd, Hyderabad, India  Novartis Pharmaceuticals Corporation, West Roxbury, MA  Novartis, Shanghai, China, People's Republic of  Novartis Pharma AG, Basel, Switzerland  Montreal Neurological Institute, McGill Univ, Montreal, QC, Canada  University of Colorado, Aurora, CO  University Clinic Dresden, Dresden, Germany  

  • View Abstract
  • View Disclosure

Ublituximab Significantly Reduces Radiological Disease Activity at 12 Weeks: Post-hoc analysis of Participants with Highly Active Disease in the ULTIMATE I & II Phase 3 Studies

Author:Robertson, Derrick   Hartung, Hans-Peter   Arnold, Douglas   Lee, Lily   Gocke, Anne   Mok, Koby   Alvarez, Enrique   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.017  

Author Institution:University of South Florida, Tampa, FL  Heinrich Heine University Medical Faculty , Dusseldorf, Germany  Montreal Neurological Institute, McGill Univ, Montreal, QC, Canada  TG Therapeutics, New York, NY  TG Therapeutics, Seal Beach, CA  University of Colorado, Aurora, CO  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com